Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease
Location: CPMC (San Francisco)
Please Contact: ClinicalResearch@sutterhealth.org about study ENVISION
Principal Investigator
Co-Investigator(s)
Related Studies
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD